Smart Biodegradable Suture BioThread Deep Dive: Sutures Automatically Release Drugs and Dissolve After Wound Closure

Swiss medical materials company TissueLabs released the BioThread smart biodegradable suture in late October. This product embeds a microcapsule drug delivery system and pH-responsive degradation mechanism into traditional absorbable sutures.

BioThreads suture material is poly(lactic-co-glycolic acid) (PLGA), with thousands of drug-loaded microcapsules roughly 5 micrometers in diameter embedded within the fiber. When the pH of surrounding tissue changes due to inflammatory response, the microcapsule wall dissolves, releasing antibiotics or anti-inflammatory drugs.

TissueLabs founder and CEO Maria Schneider explained the clinical significance. Traditional post-surgery antibiotic prophylaxis requires patients to take medication separately, with risks of missed doses or resistance development. BioThread continuously releases drugs locally at the wound site, increasing local drug concentration while reducing systemic side effects.

In clinical trials at University Hospital Zurich, surgical site infection rates dropped from 8.2% with traditional sutures to 1.1% when BioThread was used for abdominal incision closure. The sutures fully degrade by day 14 post-surgery, eliminating the need for removal.

BioThread has received CE marking and FDA 510(k) clearance. TissueLabs plans to launch first in Europe, priced at roughly 3x traditional absorbable sutures. A second-generation product integrating pH and temperature sensors is in development, which will transmit wound healing data to physicians via near-field communication.

However, precise control of microcapsule drug release remains challenging. University of Tokyo biomaterials professor Tanaka Shuji noted that inflammatory response intensity varies widely between patients, potentially causing drug release to be too fast or too slow.